ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE000MLMNYS0
Stock Name / FundiShares S&P 500 Equal Weight UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerEWSP.AS(USD) CXE
ETF TickerEWSP.LS(GBP) CXE
ETF TickerEWSP.MI(EUR) CXE
ETF TickerEWSP(EUR) ETF Plus

Holdings detail for CRL

Stock NameCreightons Plc
TickerCRL(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0002341666
LEI213800WROWAJUBGSAJ57

Show aggregate CRL holdings

News associated with CRL

Charles River Laboratories International (NYSE:CRL) Downgraded to “Buy” Rating by Wall Street Zen
Wall Street Zen lowered shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a strong-buy rating to a buy rating in a report issued on Sunday morning. Several other research firms also recently issued reports on CRL. Evercore ISI lifted their price target on Charles River Laboratories International from $180.00 to $190.00 and […] - 2025-09-22 03:13:04
Charles River CFO Flavia Pease To Step Down; Michael Knell Appointed Interim CFO
(RTTNews) - Charles River Laboratories International, Inc. (CRL) announced Tuesday that Flavia H. Pease, corporate executive vice president and chief financial officer, has resigned effective September 29, 2025, to pursue another opportunity. - 2025-09-16 08:28:15
Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $175.69
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation to […] - 2025-08-29 04:49:03
Wall Street Zen Downgrades Charles River Laboratories International (NYSE:CRL) to Buy
Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. CRL has been the topic of a number of other reports. Robert W. Baird upped their price objective on Charles […] - 2025-08-19 02:50:57
Maryland State Retirement & Pension System Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Maryland State Retirement & Pension System lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,387 shares of the medical research company’s stock after […] - 2025-08-17 05:17:00
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 577,322 shares of the medical research company’s stock after purchasing an additional 24,347 […] - 2025-08-13 05:42:56
Federated Hermes Inc. Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Federated Hermes Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 90.6% in the first quarter, Holdings Channel reports. The fund owned 225 shares of the medical research company’s stock after selling 2,172 shares during the quarter. Federated Hermes Inc.’s holdings in Charles River Laboratories International were worth $34,000 […] - 2025-08-12 05:06:53
Analysts Expect 10% Gains Ahead For The Holdings of SPUS
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-11 10:38:26
Kestra Private Wealth Services LLC Sells 115 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Kestra Private Wealth Services LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,929 shares of the medical research company’s stock after selling 115 […] - 2025-07-28 05:24:49
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 5,938 shares of the medical research company’s stock after selling 179 shares during the period. Mutual of America Capital Management LLC’s holdings […] - 2025-07-22 07:06:50
Arizona State Retirement System Sells 336 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Arizona State Retirement System decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,659 shares of the medical research company’s stock after selling 336 shares during the quarter. Arizona […] - 2025-07-18 05:10:58
Nisa Investment Advisors LLC Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Nisa Investment Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,737 shares of the medical research company’s stock after selling 1,417 shares during […] - 2025-07-16 05:44:56
Brown Advisory Inc. Has $334,000 Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Brown Advisory Inc. lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 84.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,219 shares of the medical research company’s stock after selling 12,506 shares during the period. Brown Advisory […] - 2025-07-16 04:56:59
Teacher Retirement System of Texas Takes $1.23 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Teacher Retirement System of Texas acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 8,180 shares of the medical research company’s stock, valued at approximately $1,231,000. Several other hedge funds also recently modified their holdings of the stock. Aaron […] - 2025-07-13 06:14:56
Charles River Laboratories International Reaches Analyst Target Price
In recent trading, shares of Charles River Laboratories International Inc. (Symbol: CRL) have crossed above the average analyst 12-month target price of $158.64, changing hands for $158.97/share. When a stock reaches the target an analyst has set, the analyst logically has two w - 2025-07-10 07:56:40
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of “Hold” by Analysts
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average rating of “Hold” from the sixteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-07-07 04:26:46
New York State Teachers Retirement System Sells 4,446 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
New York State Teachers Retirement System lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,784 shares of the medical research company’s stock after selling 4,446 shares […] - 2025-07-06 07:56:57
Sequoia Financial Advisors LLC Has $264,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Sequoia Financial Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.6% in the first quarter, HoldingsChannel.com reports. The fund owned 1,755 shares of the medical research company’s stock after selling 207 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Charles River Laboratories International […] - 2025-07-04 04:45:03
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,723 shares of the medical research company’s stock after selling 247 shares during the period. […] - 2025-07-03 04:26:50
Bessemer Group Inc. Sells 16,538 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Bessemer Group Inc. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 70.5% during the first quarter, HoldingsChannel.com reports. The fund owned 6,935 shares of the medical research company’s stock after selling 16,538 shares during the quarter. Bessemer Group Inc.’s holdings in Charles River Laboratories International were worth $1,044,000 at […] - 2025-07-01 05:46:49
Asset Management One Co. Ltd. Sells 17,428 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Asset Management One Co. Ltd. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 92.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,490 shares of the medical research company’s stock after selling 17,428 shares during the […] - 2025-07-01 04:54:50
Congress Trade: Representative Jefferson Shreve Just Disclosed New Stock Trades
Representative Jefferson Shreve just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Jefferson Shreve and other politicians. - 2025-06-23 10:13:39
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Blue Trust Inc.
Blue Trust Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 60.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,407 shares of the medical research company’s stock after acquiring an additional 904 shares during the period. Blue Trust Inc.’s holdings in Charles River Laboratories International […] - 2025-06-23 06:18:50
Yousif Capital Management LLC Has $856,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Yousif Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the first quarter, Holdings Channel.com reports. The firm owned 5,687 shares of the medical research company’s stock after selling 215 shares during the period. Yousif Capital Management LLC’s holdings in Charles River Laboratories […] - 2025-06-20 04:32:47
Tuesday Sector Laggards: Healthcare, Technology & Communications
The worst performing sector as of midday Tuesday is the Healthcare sector, showing a 1.4% loss. Within the sector, Charles River Laboratories International Inc. (Symbol: CRL) and Align Technology Inc (Symbol: ALGN) are two large stocks that are lagging, showing a loss of 4.4% an - 2025-06-17 15:32:11
Fifth Third Bancorp Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Fifth Third Bancorp lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,747 shares of the medical research company’s stock after selling 2,030 shares during the […] - 2025-06-16 05:32:50
Handelsbanken Fonder AB Has $1.74 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Handelsbanken Fonder AB reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,537 shares of the medical research company’s stock after selling 900 shares during the […] - 2025-06-15 06:40:51
Congress Asset Management Co. Sells 1,482 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Congress Asset Management Co. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,879 shares of the medical research company’s stock after selling 1,482 shares during […] - 2025-06-10 05:04:52
Rhumbline Advisers Has $13.06 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Rhumbline Advisers boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the first quarter, HoldingsChannel reports. The firm owned 86,730 shares of the medical research company’s stock after acquiring an additional 3,405 shares during the period. Rhumbline Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-06-09 06:02:56
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL)
Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the medical research company’s stock, valued at approximately $3,583,000. A number of other […] - 2025-06-02 05:58:52

iShares S&P 500 Equal Weight UCITS ETF USD (Acc) CRL holdings

DateNumber of CRL Shares HeldBase Market Value of CRL SharesLocal Market Value of CRL SharesChange in CRL Shares HeldChange in CRL Base ValueCurrent Price per CRL Share HeldPrevious Price per CRL Share Held
2025-12-03 (Wednesday)51,239CRL holding increased by 140USD 9,462,306CRL holding increased by 532245USD 9,462,306140USD 532,245 USD 184.67 USD 174.76
2025-12-02 (Tuesday)51,099USD 8,930,061CRL holding decreased by -67962USD 8,930,0610USD -67,962 USD 174.76 USD 176.09
2025-12-01 (Monday)51,099CRL holding increased by 175USD 8,998,023CRL holding decreased by -73578USD 8,998,023175USD -73,578 USD 176.09 USD 178.14
2025-11-28 (Friday)50,924CRL holding increased by 385USD 9,071,601CRL holding increased by 28152USD 9,071,601385USD 28,152 USD 178.14 USD 178.94
2025-11-26 (Wednesday)50,539USD 9,043,449CRL holding increased by 44980USD 9,043,4490USD 44,980 USD 178.94 USD 178.05
2025-11-25 (Tuesday)50,539USD 8,998,469CRL holding increased by 384602USD 8,998,4690USD 384,602 USD 178.05 USD 170.44
2025-11-24 (Monday)50,539CRL holding increased by 630USD 8,613,867CRL holding increased by 247122USD 8,613,867630USD 247,122 USD 170.44 USD 167.64
2025-11-21 (Friday)49,909CRL holding increased by 70USD 8,366,745CRL holding increased by 288840USD 8,366,74570USD 288,840 USD 167.64 USD 162.08
2025-11-20 (Thursday)49,839USD 8,077,905CRL holding increased by 21929USD 8,077,9050USD 21,929 USD 162.08 USD 161.64
2025-11-19 (Wednesday)49,839USD 8,055,976CRL holding decreased by -44357USD 8,055,9760USD -44,357 USD 161.64 USD 162.53
2025-11-18 (Tuesday)49,839USD 8,100,333CRL holding decreased by -10466USD 8,100,3330USD -10,466 USD 162.53 USD 162.74
2025-11-17 (Monday)49,839USD 8,110,799CRL holding decreased by -252684USD 8,110,7990USD -252,684 USD 162.74 USD 167.81
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRL by Blackrock for IE000MLMNYS0

Show aggregate share trades of CRL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03BUY140185.825180.000 180.582GBX 25,282 163.45
2025-12-01BUY175180.950175.710 176.234GBX 30,841 163.35
2025-11-28BUY385178.530176.930 177.090GBX 68,180 163.29
2025-11-24BUY630171.720167.450 167.877GBX 105,763 163.13
2025-11-21BUY70172.390157.490 158.980GBX 11,129 163.11
2025-11-11SELL-35175.550167.600 168.395GBX -5,894 162.99 Loss of -189 on sale
2025-11-07BUY245171.500165.740 166.316GBX 40,747 162.94
2025-11-05SELL-2,380170.140160.010 161.023GBX -383,235 162.88 Profit of 4,430 on sale
2025-10-29SELL-1,879180.150191.410 190.284GBX -357,544 162.51 Loss of -52,194 on sale
2025-10-24SELL-380197.040199.660 199.398GBX -75,771 162.07 Loss of -14,184 on sale
2025-10-23SELL-70190.970195.250 194.822GBX -13,638 161.93 Loss of -2,302 on sale
2025-10-22BUY105187.000190.690 190.321GBX 19,984 161.82
2025-10-20SELL-805184.140184.230 184.221GBX -148,298 161.58 Loss of -18,224 on sale
2025-10-17SELL-420178.520178.770 178.745GBX -75,073 161.50 Loss of -7,242 on sale
2025-10-16SELL-175174.950177.750 177.470GBX -31,057 161.44 Loss of -2,806 on sale
2025-10-15SELL-435170.720173.020 172.790GBX -75,164 161.39 Loss of -4,959 on sale
2025-10-03BUY140177.330181.450 181.038GBX 25,345 161.16
2025-10-02SELL-1,400175.360178.190 177.907GBX -249,070 161.09 Loss of -23,547 on sale
2025-10-01SELL-1,352170.480170.660 170.642GBX -230,708 161.04 Loss of -12,980 on sale
2025-09-30SELL-35156.460156.790 156.757GBX -5,486 161.06 Profit of 151 on sale
2025-09-29SELL-456146.990148.920 148.727GBX -67,820 161.14 Profit of 5,658 on sale
2025-09-26SELL-35148.560149.170 149.109GBX -5,219 161.20 Profit of 423 on sale
2025-09-25BUY455145.570148.390 148.108GBX 67,389 161.28
2025-09-24BUY1,712149.450150.870 150.728GBX 258,046 161.34
2025-09-18BUY68156.990157.630 157.566GBX 10,714 161.36
2025-09-10SELL-34153.270157.970 157.500GBX -5,355 161.51 Profit of 136 on sale
2025-09-08SELL-34162.000165.110 164.799GBX -5,603 161.53 Loss of -111 on sale
2025-08-19BUY62158.480160.000 159.848GBX 9,911 161.56
2025-07-29BUY36178.450179.420 179.323GBX 6,456 161.37
2025-07-23SELL-102167.950169.600 169.435GBX -17,282 161.15 Loss of -845 on sale
2025-07-22SELL-204163.360167.830 167.383GBX -34,146 161.14 Loss of -1,273 on sale
2025-07-21SELL-68149.790155.690 155.100GBX -10,547 161.21 Profit of 415 on sale
2025-07-11SELL-102159.400162.660 162.334GBX -16,558 161.22 Loss of -114 on sale
2025-07-10SELL-408163.660168.120 167.674GBX -68,411 161.20 Loss of -2,641 on sale
2025-07-09SELL-136158.970163.590 163.128GBX -22,185 161.21 Loss of -260 on sale
2025-07-08SELL-442158.390160.000 159.839GBX -70,649 161.23 Profit of 615 on sale
2025-07-03SELL-578157.120158.720 158.560GBX -91,648 161.32 Profit of 1,597 on sale
2025-07-02SELL-105157.490158.380 158.291GBX -16,621 161.34 Profit of 321 on sale
2025-06-27SELL-1,666150.010152.630 152.368GBX -253,845 161.47 Profit of 15,165 on sale
2025-06-25BUY34150.210152.510 152.280GBX 5,178 161.60
2025-06-24SELL-1,258148.400149.680 149.552GBX -188,136 161.68 Profit of 15,256 on sale
2025-06-18SELL-168145.290147.100 146.919GBX -24,682 161.88 Profit of 2,514 on sale
2025-06-17SELL-308145.050150.540 149.991GBX -46,197 161.99 Profit of 3,694 on sale
2025-06-11SELL-84151.110154.430 154.098GBX -12,944 162.27 Profit of 686 on sale
2025-06-10SELL-196151.000152.430 152.287GBX -29,848 162.34 Profit of 1,971 on sale
2025-06-06SELL-56144.700145.650 145.555GBX -8,151 162.55 Profit of 952 on sale
2025-06-05SELL-476141.200144.880 144.512GBX -68,788 162.69 Profit of 8,654 on sale
2025-06-02SELL-2,268135.040135.440 135.400GBX -307,087 163.17 Profit of 62,977 on sale
2025-05-30SELL-504135.630136.940 136.809GBX -68,952 163.35 Profit of 13,378 on sale
2025-05-29SELL-56137.700138.600 138.510GBX -7,757 163.53 Profit of 1,401 on sale
2025-05-27SELL-56138.650140.650 140.450GBX -7,865 163.88 Profit of 1,312 on sale
2025-05-23SELL-84136.730137.000 136.973GBX -11,506 164.26 Profit of 2,292 on sale
2025-05-16SELL-420140.970142.600 142.437GBX -59,824 165.16 Profit of 9,543 on sale
2025-05-15SELL-84138.890139.380 139.331GBX -11,704 165.35 Profit of 2,185 on sale
2025-05-13SELL-28144.020145.640 145.478GBX -4,073 165.70 Profit of 566 on sale
2025-05-12SELL-196143.080147.640 147.184GBX -28,848 165.87 Profit of 3,662 on sale
2025-05-09SELL-168138.790143.460 142.993GBX -24,023 166.07 Profit of 3,877 on sale
2025-05-08SELL-812141.360143.860 143.610GBX -116,611 166.25 Profit of 18,388 on sale
2025-05-07SELL-56136.970144.770 143.990GBX -8,063 166.48 Profit of 1,259 on sale
2025-05-06BUY24115.410120.020 119.559GBX 2,869 166.87
2025-05-01BUY1,064116.890120.140 119.815GBX 127,483 168.01
2025-04-30BUY588118.620118.690 118.683GBX 69,786 168.39
2025-04-29SELL-112117.290117.860 117.803GBX -13,194 168.80 Profit of 5,712 on sale
2025-04-28SELL-140115.080117.160 116.952GBX -16,373 169.23 Profit of 7,319 on sale
2025-04-25BUY56114.660115.250 115.191GBX 6,451 169.67
2025-04-24SELL-28115.760115.940 115.922GBX -3,246 170.11 Profit of 1,517 on sale
2025-04-22SELL-3,752106.890107.290 107.250GBX -402,402 171.14 Profit of 239,699 on sale
2025-04-17SELL-1,708106.050106.230 106.212GBX -181,410 172.82 Profit of 113,765 on sale
2025-04-16BUY56104.250107.230 106.932GBX 5,988 173.41
2025-04-15BUY56105.920107.580 107.414GBX 6,015 173.99
2025-04-11SELL-1,76499.750101.360 101.199GBX -178,515 175.23 Profit of 130,589 on sale
2025-04-09BUY140139.070139.310 139.286GBX 19,500 176.22
2025-04-08BUY28123.610137.960 136.525GBX 3,823 176.70
2025-04-07BUY504134.070139.160 138.651GBX 69,880 177.09
2025-04-04BUY308136.900140.150 139.825GBX 43,066 177.45
2025-04-02BUY196149.280150.160 150.072GBX 29,414 177.72
2025-04-01BUY2,212145.990151.370 150.832GBX 333,640 178.01
2025-03-31BUY84150.520153.820 153.490GBX 12,893 178.27
2025-03-25BUY28161.350168.000 167.335GBX 4,685 179.05
2025-03-21BUY3,511167.280167.940 167.874GBX 589,406 179.29
2025-03-20BUY54165.350171.710 171.074GBX 9,238 179.43
2025-03-18BUY135176.940177.120 177.102GBX 23,909 179.52
2025-03-17BUY17175.010175.600 175.541GBX 2,984 179.56
2025-03-14SELL-10171.040171.630 171.571GBX -1,716 179.65 Profit of 81 on sale
2025-03-13SELL-1,750166.930172.250 171.718GBX -300,506 179.79 Profit of 14,123 on sale
2025-03-12BUY324170.590171.190 171.130GBX 55,446 179.89
2025-03-11BUY324166.630175.070 174.226GBX 56,449 180.03
2025-03-07BUY108175.920177.240 177.108GBX 19,128 180.13
2025-03-06BUY378169.270170.610 170.476GBX 64,440 180.25
2025-03-05BUY2,052167.550167.990 167.946GBX 344,625 180.40
2025-03-04BUY108164.310166.710 166.470GBX 17,979 180.58
2025-03-03BUY135163.500166.720 166.398GBX 22,464 180.78
2025-02-28BUY270165.310165.820 165.769GBX 44,758 180.96
2025-02-27BUY243164.880167.960 167.652GBX 40,739 181.16
2025-02-26SELL-140167.960170.440 170.192GBX -23,827 181.31 Profit of 1,557 on sale
2025-02-25SELL-27167.100172.430 171.897GBX -4,641 181.49 Profit of 259 on sale
2025-02-24BUY27170.510172.450 172.256GBX 4,651 181.62
2025-02-20SELL-351162.250168.020 167.443GBX -58,772 182.10 Profit of 5,146 on sale
2025-02-19BUY108165.000166.440 166.296GBX 17,960 182.32
2025-02-18BUY110154.390155.690 155.560GBX 17,112 182.69
2025-02-13BUY3,078153.170155.290 155.078GBX 477,330 183.91
2025-02-12BUY918154.000154.730 154.657GBX 141,975 184.32
2025-02-11BUY756154.900158.480 158.122GBX 119,540 184.73
2025-02-07BUY81163.790166.860 166.553GBX 13,491 185.39
2025-02-06BUY1,080166.270168.840 168.583GBX 182,070 185.66
2025-02-05BUY540165.870166.120 166.095GBX 89,691 185.96
2025-02-04BUY405163.120169.670 169.015GBX 68,451 186.30
2025-02-03SELL-2,349161.620164.280 164.014GBX -385,269 186.67 Profit of 53,218 on sale
2025-01-31BUY216164.760167.090 166.857GBX 36,041 187.01
2025-01-30BUY27165.570166.200 166.137GBX 4,486 187.34
2025-01-29BUY459161.640163.000 162.864GBX 74,755 187.75
2025-01-28BUY162163.640167.470 167.087GBX 27,068 188.14
2025-01-27BUY162165.840168.550 168.279GBX 27,261 188.50
2025-01-24BUY162164.970168.150 167.832GBX 27,189 188.90
2025-01-23BUY459166.860169.010 168.795GBX 77,477 189.27
2025-01-22BUY270168.220170.830 170.569GBX 46,054 189.63
2025-01-21BUY1,593169.810171.750 171.556GBX 273,289 189.98
2025-01-17BUY324163.500167.500 167.100GBX 54,140 190.94
2025-01-15BUY162173.910182.250 181.416GBX 29,389 191.74
2025-01-13BUY459190.140190.680 190.626GBX 87,497 192.04
2025-01-10BUY352186.120188.260 188.046GBX 66,192 192.16
2024-12-31BUY81184.600185.980 185.842GBX 15,053 192.71
2024-12-30BUY108183.420185.100 184.932GBX 19,973 192.92
2024-12-27BUY527186.160188.320 188.104GBX 99,131 193.07
2024-12-23BUY162185.390186.750 186.614GBX 30,231 193.58
2024-12-20BUY3,432185.770188.040 187.813GBX 644,574 193.78
2024-12-19BUY300182.150185.050 184.760GBX 55,428 194.08
2024-12-17BUY229189.330199.450 198.438GBX 45,442 194.50
2024-12-16BUY75190.070193.820 193.445GBX 14,508 194.62
2024-12-13BUY125190.460194.170 193.799GBX 24,225 194.74
2024-12-11BUY75193.550200.100 199.445GBX 14,958 194.78
2024-12-10BUY50197.050202.720 202.153GBX 10,108 194.71
2024-12-09BUY50201.750202.570 202.488GBX 10,124 194.49
2024-12-05SELL-150191.540198.830 198.101GBX -29,715 194.67 Loss of -514 on sale
2024-12-04BUY26199.350201.420 201.213GBX 5,232 194.51
2024-12-02BUY100201.250203.010 202.834GBX 20,283 194.09
2024-11-29BUY450199.060201.290 201.067GBX 90,480 193.89
2024-11-27BUY100199.590202.560 202.263GBX 20,226 193.42
2024-11-26BUY250197.750200.200 199.955GBX 49,989 193.23
2024-11-25BUY3,100201.300202.870 202.713GBX 628,410 192.87
2024-11-22BUY75195.770198.180 197.939GBX 14,845 192.73
2024-11-21BUY75194.190194.880 194.811GBX 14,611 192.65
2024-11-20BUY325187.900188.320 188.278GBX 61,190 192.90
2024-11-19SELL-325186.100188.380 188.152GBX -61,149 193.28 Profit of 1,667 on sale
2024-11-18BUY1,500187.500187.930 187.887GBX 281,830 193.62
2024-11-12BUY300215.940221.600 221.034GBX 66,310 192.23
2024-11-11BUY75220.690222.100 221.959GBX 16,647 190.33
2024-11-08BUY301215.390216.150 216.074GBX 65,038 188.54
2024-11-07BUY506210.290217.600 216.869GBX 109,736 186.87
2024-11-06BUY225214.200230.020 228.438GBX 51,399 184.59
2024-11-05BUY50188.680189.180 189.130GBX 9,456 184.22
2024-11-04BUY255182.480185.860 185.522GBX 47,308 184.39
2024-11-01BUY125180.960184.040 183.732GBX 22,966 184.77
2024-10-30BUY75181.390186.370 185.872GBX 13,940 186.14
2024-10-29BUY475184.000186.460 186.214GBX 88,452 186.50
2024-10-25BUY100182.120184.550 184.307GBX 18,431 187.58
2024-10-24BUY75182.730186.320 185.961GBX 13,947 189.20
2024-10-22BUY150185.940191.010 190.503GBX 28,575 195.04
2024-10-21BUY125195.040197.640 197.380GBX 24,672 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1998,1391131,07574.9%
2025-09-1862,9972121,43651.9%
2025-09-1792,1290727,00512.7%
2025-09-16115,39612317,67336.3%
2025-09-1566,3561151,09343.9%
2025-09-1277,5570176,81743.9%
2025-09-1187,9991204,23743.1%
2025-09-10122,6560398,56430.8%
2025-09-09125,4020471,64226.6%
2025-09-08178,3420414,72943.0%
2025-09-0576,2640192,66839.6%
2025-09-0494,7920179,53352.8%
2025-09-03139,6460216,26564.6%
2025-09-02112,81930183,91061.3%
2025-08-29105,9651,040180,20658.8%
2025-08-28183,9714248,97873.9%
2025-08-2771,8910134,03453.6%
2025-08-26109,85319166,15266.1%
2025-08-25147,16623300,78148.9%
2025-08-22251,1260414,08560.6%
2025-08-21102,1520149,37668.4%
2025-08-20152,7210215,94670.7%
2025-08-19118,8310172,88768.7%
2025-08-1893,0280164,64156.5%
2025-08-1596,5001180,16553.6%
2025-08-14147,9520251,45658.8%
2025-08-13820,20601,075,15376.3%
2025-08-12299,3220438,69968.2%
2025-08-11192,9170365,05852.8%
2025-08-0892,08966222,12841.5%
2025-08-07326,647522550,23059.4%
2025-08-06532,4347,827888,87359.9%
2025-08-05283,1486539,93852.4%
2025-08-04124,11154248,83449.9%
2025-08-01162,441300281,62257.7%
2025-07-31125,6480228,70654.9%
2025-07-30115,4870188,12161.4%
2025-07-29181,1590275,84365.7%
2025-07-28198,89649321,94161.8%
2025-07-25162,642111293,83155.4%
2025-07-24385,658456820,47247.0%
2025-07-23150,6500346,02043.5%
2025-07-22205,73626821,85325.0%
2025-07-21132,794101445,92029.8%
2025-07-1893,150207186,54249.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy